AMO's IOL to be reimbursed in US

Following designation of New Technology Intraocular Lens (NTIOL) status by the Centers for Medicare and Medicaid Services (CMS), AMO has introduced the Tecnis 1-Piece IOL to the US market.

Related Content:

ArticlesCataract & Refractive

Removing opioid prescriptions from cataract surgery

iScan 80 OCT to launch in UK

Managing long COVID-19 symptoms that persist beyond infection